Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

COVID-19: Daily Top 10 Papers

  Drug Resistance

  Free Subscription


1 Am J Trop Med Hyg
2 Antimicrob Agents Chemother
5 Clin Infect Dis
1 Infect Control Hosp Epidemiol
2 Int J Antimicrob Agents
1 J Antimicrob Chemother
1 J Bacteriol
2 J Clin Microbiol
6 J Infect Dis
1 PLoS One

  Retrieve available abstracts of this week’s articles:
HTML format
Single Articles


  1. MUCCINI C, Spagnuolo V, Canetti D, Bigoloni A, et al
    Cerebrospinal fluid viral replication and burden of resistance in three HIV-1-infected people taking Ibalizumab with multiple drug class-wide resistance.
    AIDS. 2020;34:2152-2155.

  2. BAJEMA KL, Nance RM, Delaney JAC, Eaton E, et al
    Significant decline in heavily treatment experienced persons with HIV with limited antiretroviral treatment options in the US, 2000-2017.
    AIDS. 2020 Oct 12. doi: 10.1097/QAD.0000000000002679.
    PubMed         Abstract available

  3. YOTSUMOTO M, Hachiya A, Ichiki A, Amano K, et al
    Second-generation integrase strand inhibitors can be effective against elvitegravir-derived multiple integrase gene substitutions.
    AIDS. 2020 Sep 14. doi: 10.1097/QAD.0000000000002688.

  4. GAY CL, Neo DT, Devanathan AS, Kuruc JD, et al
    Efficacy, pharmacokinetics and neurocognitive performance of dual, NRTI-sparing antiretroviral therapy in acute HIV-infection.
    AIDS. 2020 Aug 7. doi: 10.1097/QAD.0000000000002652.
    PubMed         Abstract available

  5. INZAULE SC, Jordan MR, Cournil A, Giron-Callejas A, et al
    Tenofovir resistance in early and long-term treated patients on first-line antiretroviral therapy in eight low- and middle-income countries.
    AIDS. 2020 Jul 17. doi: 10.1097/QAD.0000000000002623.
    PubMed         Abstract available

    Am J Trop Med Hyg

  6. GINN O, Berendes D, Wood A, Bivins A, et al
    Open Waste Canals as Potential Sources of Antimicrobial Resistance Genes in Aerosols in Urban Kanpur, India.
    Am J Trop Med Hyg. 2021 Mar 8. pii: tpmd201222. doi: 10.4269/ajtmh.20-1222.
    PubMed         Abstract available

    Antimicrob Agents Chemother

  7. MOHD SAZLLY LIM S, Heffernan AJ, Roberts JA, Sime FB, et al
    Semi-mechanistic PK/PD modelling of fosfomycin and sulbactam combination against carbapenem-resistant Acinetobacter baumannii.
    Antimicrob Agents Chemother. 2021 Mar 8. pii: AAC.02472.
    PubMed         Abstract available

  8. CHO HK, Karau MJ, Greenwood-Quaintance KE, Hansford KA, et al
    In Vitro Activity of Vancapticin MCC5145 against Methicillin-Resistant Staphylococcus aureus from Periprosthetic Joint Infection.
    Antimicrob Agents Chemother. 2021 Mar 8. pii: AAC.02443.
    PubMed         Abstract available


  9. BASNYAT B, Qamar FN, Rupali P, Ahmed T, et al
    Enteric fever.
    BMJ. 2021;372:n437.

    Clin Infect Dis

  10. STEWART AG, Harris PNA, Chatfield M, Evans SR, et al
    Modern Clinician-initiated Clinical Trials to Determine Optimal Therapy for Multidrug-resistant Gram-negative Infections.
    Clin Infect Dis. 2020;71:433-439.
    PubMed         Abstract available

  11. DIPIPPO AJ, Kontoyiannis DP
    Azole-Associated Pseudohyperaldosteronism: A Class Effect or Azole-Specific?
    Clin Infect Dis. 2020;71:467-468.

  12. VANNICE K, Ricaldi J, Nanduri S, Fang FC, et al
    Streptococcus pyogenes pbp2x Mutation Confers Reduced Susceptibility to beta-lactam antibiotics.
    Clin Infect Dis. 2019 Oct 20. pii: 5601183. doi: 10.1093/cid/ciz1000.
    PubMed         Abstract available

  13. POGUE JM, Kaye KS, Veve MP, Patel TS, et al
    Ceftolozane/Tazobactam vs Polymyxin or Aminoglycoside-based Regimens for the Treatment of Drug-resistant Pseudomonas Aeruginosa.
    Clin Infect Dis. 2019 Sep 23. pii: 5572677. doi: 10.1093.
    PubMed         Abstract available

  14. POPOVICH KJ, Snitkin ES, Zawitz C, Aroutcheva A, et al
    Frequent MRSA Introductions into an Inner-City Jail: Indications of Community Transmission Networks.
    Clin Infect Dis. 2019 Aug 20. pii: 5551540. doi: 10.1093.
    PubMed         Abstract available

    Infect Control Hosp Epidemiol

  15. SHINOHARA DR, Dos Santos Saalfeld SM, Martinez HV, Altafini DD, et al
    Outbreak of endemic carbapenem-resistant A. baumannii in a COVID-19-specific intensive care unit.
    Infect Control Hosp Epidemiol. 2021 Mar 9:1-7. doi: 10.1017/ice.2021.

    Int J Antimicrob Agents

  16. LO SCIUTO A, Cervoni M, Stefanelli R, Mancone C, et al
    Effect of lipid A aminoarabinosylation on Pseudomonas aeruginosa colistin resistance and fitness.
    Int J Antimicrob Agents. 2020;55:105957.
    PubMed         Abstract available

  17. JEANVOINE A, Bouxom H, Leroy J, Gbaguidi-Haore H, et al
    Resistance to third-generation cephalosporins in Escherichia coli in the French community: The times they are a-changin'?
    Int J Antimicrob Agents. 2020;55:105909.
    PubMed         Abstract available

    J Antimicrob Chemother

  18. FERNANDEZ-HUERTA M, Serra-Pladevall J, Pumarola T, Pich OQ, et al
    Comment on: Lower mgpB diversity in macrolide-resistant Mycoplasma genitalium infecting men visiting two sexually transmitted infection clinics in Montpellier, France.
    J Antimicrob Chemother. 2021 Feb 28. pii: 6154381. doi: 10.1093.

    J Bacteriol

  19. PARTHASARATHY S, Jordan LD, Schwarting N, Woods MA, et al
    Involvement of chromosomally encoded homologs of the RRNPP protein family in Enterococcus faecalis biofilm formation and UTI pathogenesis.
    J Bacteriol. 2020 Jun 15. pii: JB.00063-20. doi: 10.1128/JB.00063.
    PubMed         Abstract available

    J Clin Microbiol

  20. MANNION A, Dzink-Fox J, Shen Z, Piazuelo MB, et al
    Helicobacter pylori antimicrobial resistance and gene variants in high and low gastric cancer risk populations.
    J Clin Microbiol. 2021 Mar 10. pii: JCM.03203-20. doi: 10.1128/JCM.03203.
    PubMed         Abstract available

  21. LEE DYJ, Ashcroft MM, Chow EPF, Sait M, et al
    Reflex detection of ciprofloxacin resistance in Neisseria gonorrhoeae using the SpeeDx ResistancePlus(R) GC assay.
    J Clin Microbiol. 2021 Mar 3. pii: JCM.00089-21. doi: 10.1128/JCM.00089.
    PubMed         Abstract available

    J Infect Dis

  22. RANALLO RT, Clifford McDonald L, Laufer Halpin A, Hiltke T, et al
    The State of Microbiome Science at the Intersection of Infectious Diseases and Antimicrobial Resistance.
    J Infect Dis. 2021 Mar 1. pii: 6154668. doi: 10.1093.
    PubMed         Abstract available

  23. STRAY K, Perron M, Porter DP, Anderson F, et al
    Drug Resistance Assessment Following Administration of Respiratory Syncytial Virus (RSV) Fusion Inhibitor Presatovir to Participants Experimentally Infected With RSV.
    J Infect Dis. 2020;222:1468-1477.
    PubMed         Abstract available

  24. INCE WL, Smith FB, O'Rear JJ, Thomson M, et al
    Treatment-emergent influenza virus PA substitutions independent of those at I38 associated with reduced baloxavir susceptibility and virus rebound in trials of baloxavir marboxil.
    J Infect Dis. 2020 Apr 7. pii: 5816798. doi: 10.1093.
    PubMed         Abstract available

  25. KEBRIAEI R, Stamper KC, Singh KV, Khan A, et al
    Mechanistic Insights into the Differential Efficacy of Daptomycin plus beta-Lactam Combinations against Daptomycin-Resistant Enterococcus faecium.
    J Infect Dis. 2020 Jun 8. pii: 5854807. doi: 10.1093.
    PubMed         Abstract available

    Sepsis Perspective 2020.
    J Infect Dis. 2020;222.

  27. BUSCH LM, Kadri SS
    Antimicrobial Treatment Duration in Sepsis and Serious Infections.
    J Infect Dis. 2020;222.
    PubMed         Abstract available

    PLoS One

  28. ALHUBAIL A, Sewify M, Messenger G, Masoetsa R, et al
    Microbiological profile of diabetic foot ulcers in Kuwait.
    PLoS One. 2020;15:e0244306.
    PubMed         Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Drug Resistance is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.